UBS Group’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.03M Buy
212,484
+116,736
+122% +$1.66M ﹤0.01% 3489
2025
Q1
$1.24M Sell
95,748
-39,604
-29% -$514K ﹤0.01% 4018
2024
Q4
$1.8M Buy
135,352
+116,335
+612% +$1.55M ﹤0.01% 3799
2024
Q3
$114K Buy
19,017
+7,999
+73% +$48K ﹤0.01% 5070
2024
Q2
$36.2K Buy
11,018
+9,058
+462% +$29.8K ﹤0.01% 5785
2024
Q1
$7.35K Sell
1,960
-1,792
-48% -$6.72K ﹤0.01% 6220
2023
Q4
$16.4K Buy
3,752
+2,830
+307% +$12.4K ﹤0.01% 6021
2023
Q3
$3.85K Buy
+922
New +$3.85K ﹤0.01% 6362
2023
Q2
Sell
-5,387
Closed -$20.7K 7966
2023
Q1
$20.7K Buy
5,387
+1,448
+37% +$5.58K ﹤0.01% 5955
2022
Q4
$11.1K Sell
3,939
-2,494
-39% -$7.03K ﹤0.01% 7244
2022
Q3
$14K Buy
6,433
+2,665
+71% +$5.8K ﹤0.01% 6804
2022
Q2
$10K Sell
3,768
-787
-17% -$2.09K ﹤0.01% 6917
2022
Q1
$20K Buy
4,555
+476
+12% +$2.09K ﹤0.01% 6402
2021
Q4
$17K Buy
+4,079
New +$17K ﹤0.01% 6939
2021
Q3
Sell
-5,363
Closed -$33K 8462
2021
Q2
$33K Buy
5,363
+871
+19% +$5.36K ﹤0.01% 5747
2021
Q1
$33K Sell
4,492
-1,053
-19% -$7.74K ﹤0.01% 5911
2020
Q4
$45K Buy
5,545
+1,541
+38% +$12.5K ﹤0.01% 5283
2020
Q3
$32K Sell
4,004
-779
-16% -$6.23K ﹤0.01% 5088
2020
Q2
$26K Sell
4,783
-1,948
-29% -$10.6K ﹤0.01% 5528
2020
Q1
$28K Buy
6,731
+4,181
+164% +$17.4K ﹤0.01% 5368
2019
Q4
$18K Buy
+2,550
New +$18K ﹤0.01% 5867
2019
Q3
Sell
-1,189
Closed -$9K 7036
2019
Q2
$9K Sell
1,189
-7,353
-86% -$55.7K ﹤0.01% 6245
2019
Q1
$68K Buy
+8,542
New +$68K ﹤0.01% 4531